#5M5Q
RBQM Interviews

Gain insights from top industry experts, sponsors, and CROs as they share tips and visions for the future RBQM. Explore the latest strategies and innovative practices to elevate your quality management processes.


    SPONSOR
    Miguel Valenzuela

    Miguel Valenzuela

    • AD, Clinical Risk and Analytics
    • Alnylam Pharmaceuticals
    SPONSOR

    Brian Barnes

    • Director, Risk Management Strategy
    • BIONTECH
    CRO

    Jennifer Stewart

    • Executive Director, Clinical Data Sciences
    • Premier Research
    CRO

    Shawntel Swannack

    • Head, Risk-Based Quality Management
    • Emmes
    CRO

    Molly Peterson

    • Clinical Risk Manager
    • Worldwide Clinical Trials
    Complimentary Training

    Expert-Led GCP Training

    • Learn at your own pace
    • Featuring RBQM & GCP experts
    TESTIMONIALS

    RBQM Success Stories

    Hear directly from our partners about how we've helped them.

    Peter Benton President & CEO, Worldwide

    Worldwide’s RBQM team is one of the most experienced CRO teams in the industry. This, coupled with TRI’s best-in-class technology, ensures we can proactively identify and manage risks, meaning improved quality and patient safety, and, in turn, provide a better experience for sponsors and patients.

    Jeff Smith Former CEO, Alimentiv

    What truly set TriTrials apart from other vendors was their unparalleled commitment to a quality deliverable helping us effectively apply a novel approach to our operations. They achieved a deep understanding of our objectives by partnering with us on a rigorous change management process which culminated in a shared vision for the integration of their risk assessment and central monitoring solution.

    Amandeep Sonik Senior Director, RBQM, Worldwide

    The Worldwide Clinical Trials team is pleased with our continued partnership with TRI and we are excited about the milestone of having 150 clinical trials in TRI's Risk-Based Quality Management platform. This is a key benefit for our customers as it improves data quality, trial efficiency, and patient safety.

    Kelly Parish Holladay AD, RBQM, Worldwide

    It has been such a wonderful ride with our TRI partners over the last few years developing our RBQM strategy with our Sponsors and Worldwide Clinical Trials Teams! We love working with everyone at TRI and look forward to bigger and better things to come!

    RBQM NEWS

    Clinical trial quality news and views

    Subscribe to get the latest RBQM insights sent to your mailbox.

    Dose Optimization in Oncology: Advancing Clinical Trial Quality through Risk-Based Approaches

    Dose Optimization in Oncology: Advancing Clinical Trial Quality through Risk-Based Approaches

    The complexities of oncology drug development have long posed significant challenges, particularly in determining the optimal dose that balances therapeutic efficacy with patient safety. The FDA’s recent guidance on dose…

    TRI Joins Veeva’s Product Partner Program

    TRI Joins Veeva’s Product Partner Program

    Partnership will drive quality and efficiency in clinical trials through enhanced risk-based quality management integration. [Cambridge, UK – 17.10.2024] – TRI, a leading Risk-Based Quality Management (RBQM) software provider for…

    Risk-Based Clinical Data Management Takes Center Stage at SCDM 2024

    Risk-Based Clinical Data Management Takes Center Stage at SCDM 2024

    The Society for Clinical Data Management (SCDM) annual conference has always been a cornerstone for clinical data professionals, but this year’s event, held in Boston from September 30th to October…